BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

433 related articles for article (PubMed ID: 28751195)

  • 1. Antinociceptive, antiallodynic and antihyperalgesic effects of the 5-HT
    Sałat K; Kołaczkowski M; Furgała A; Rojek A; Śniecikowska J; Varney MA; Newman-Tancredi A
    Neuropharmacology; 2017 Oct; 125():181-188. PubMed ID: 28751195
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NLX-112, a highly selective 5-HT
    Newman-Tancredi A; Bardin L; Auclair A; Colpaert F; Depoortère R; Varney MA
    Brain Res; 2018 Jun; 1688():1-7. PubMed ID: 29555239
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NLX-112, a highly selective 5-HT
    Newman-Tancredi A; Depoortère R; Carilla-Durand E; Tarayre JP; Kleven M; Koek W; Bardin L; Varney MA
    Pharmacol Biochem Behav; 2018 Feb; 165():56-62. PubMed ID: 29126856
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The novel 5-HT1A receptor agonist, NLX-112 reduces l-DOPA-induced abnormal involuntary movements in rat: A chronic administration study with microdialysis measurements.
    McCreary AC; Varney MA; Newman-Tancredi A
    Neuropharmacology; 2016 Jun; 105():651-660. PubMed ID: 26777281
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NLX-112, a novel 5-HT1A receptor agonist for the treatment of L-DOPA-induced dyskinesia: Behavioral and neurochemical profile in rat.
    Iderberg H; McCreary AC; Varney MA; Kleven MS; Koek W; Bardin L; Depoortère R; Cenci MA; Newman-Tancredi A
    Exp Neurol; 2015 Sep; 271():335-50. PubMed ID: 26037043
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The selective 5-HT
    Fisher R; Hikima A; Morris R; Jackson MJ; Rose S; Varney MA; Depoortere R; Newman-Tancredi A
    Neuropharmacology; 2020 May; 167():107997. PubMed ID: 32057799
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiallodynic and antihyperalgesic activity of new 3,3-diphenyl-propionamides with anticonvulsant activity in models of pain in mice.
    Rapacz A; Obniska J; Koczurkiewicz P; Wójcik-Pszczoła K; Siwek A; Gryboś A; Rybka S; Karcz A; Pękala E; Filipek B
    Eur J Pharmacol; 2018 Feb; 821():39-48. PubMed ID: 29262297
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antinociceptive and Antiallodynic Activity of Some 3-(3-Methylthiophen-2-yl)pyrrolidine-2,5-dione Derivatives in Mouse Models of Tonic and Neuropathic Pain.
    Dziubina A; Rapacz A; Czopek A; Góra M; Obniska J; Kamiński K
    Int J Mol Sci; 2022 Apr; 23(7):. PubMed ID: 35409413
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of spinal 5-HT5A, and 5-HT1A/1B/1D, receptors in neuropathic pain induced by spinal nerve ligation in rats.
    Avila-Rojas SH; Velázquez-Lagunas I; Salinas-Abarca AB; Barragán-Iglesias P; Pineda-Farias JB; Granados-Soto V
    Brain Res; 2015 Oct; 1622():377-85. PubMed ID: 26168890
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiallodynic and antihyperalgesic activity of 3-[4-(3-trifluoromethyl-phenyl)-piperazin-1-yl]-dihydrofuran-2-one compared to pregabalin in chemotherapy-induced neuropathic pain in mice.
    Sałat K; Cios A; Wyska E; Sałat R; Mogilski S; Filipek B; Więckowski K; Malawska B
    Pharmacol Biochem Behav; 2014 Jul; 122():173-81. PubMed ID: 24726707
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antihyperalgesic effects of intrathecal perospirone in a rat model of neuropathic pain.
    Haranishi Y; Hara K; Terada T
    Pharmacol Biochem Behav; 2020 Aug; 195():172964. PubMed ID: 32504731
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serotonergically dependent antihyperalgesic and antiallodynic effects of isoliquiritin in a mouse model of neuropathic pain.
    Yu C; Zhang Y; Gao KX; Sun HT; Gong MZ; Zhao X; Ren P
    Eur J Pharmacol; 2020 Aug; 881():173184. PubMed ID: 32417324
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The selective 5-HT
    Depoortere R; Johnston TH; Fox SH; Brotchie JM; Newman-Tancredi A
    Parkinsonism Relat Disord; 2020 Sep; 78():151-157. PubMed ID: 32846366
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cannabidiol attenuates mechanical allodynia in streptozotocin-induced diabetic rats via serotonergic system activation through 5-HT1A receptors.
    Jesus CHA; Redivo DDB; Gasparin AT; Sotomaior BB; de Carvalho MC; Genaro K; Zuardi AW; Hallak JEC; Crippa JA; Zanoveli JM; da Cunha JM
    Brain Res; 2019 Jul; 1715():156-164. PubMed ID: 30898678
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Marble Burying in NMRI Male Mice Is Preferentially Sensitive to Pre- Versus Postsynaptic 5-HT1A Receptor Biased Agonists.
    Depoortere R; Bardin L; Auclair AL; Bruins Slot LA; Newman-Tancredi A
    Pharmacology; 2021; 106(1-2):114-118. PubMed ID: 32950991
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distinctive in vitro signal transduction profile of NLX-112, a potent and efficacious serotonin 5-HT
    Newman-Tancredi A; Martel JC; Cosi C; Heusler P; Lestienne F; Varney MA; Cussac D
    J Pharm Pharmacol; 2017 Sep; 69(9):1178-1190. PubMed ID: 28612503
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antihyperalgesic, Antiallodynic, and Antinociceptive Effects of Cebranopadol, a Novel Potent Nociceptin/Orphanin FQ and Opioid Receptor Agonist, after Peripheral and Central Administration in Rodent Models of Neuropathic Pain.
    Tzschentke TM; Linz K; Frosch S; Christoph T
    Pain Pract; 2017 Nov; 17(8):1032-1041. PubMed ID: 28112482
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antinociceptive activity of transient receptor potential channel TRPV1, TRPA1, and TRPM8 antagonists in neurogenic and neuropathic pain models in mice.
    Sałat K; Filipek B
    J Zhejiang Univ Sci B; 2015 Mar; 16(3):167-78. PubMed ID: 25743118
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NLX-112, a highly selective 5-HT
    Depoortère R; Bergman J; Beardsley PM; Desai RI; Paronis CA; Walentiny DM; Varney MA; Newman-Tancredi A
    Neuropharmacology; 2022 Jun; 210():109025. PubMed ID: 35276118
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of S 38093, an antagonist/inverse agonist of histamine H3 receptors, in models of neuropathic pain in rats.
    Chaumette T; Chapuy E; Berrocoso E; Llorca-Torralba M; Bravo L; Mico JA; Chalus M; Eschalier A; Ardid D; Marchand F; Sors A
    Eur J Pain; 2018 Jan; 22(1):127-141. PubMed ID: 28877402
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.